Investment
Features
FeesSafety
Academy
More
Pluang+

Cybersecurity consultant convicted for $55M DeFi theft from Uranium Finance in 2021.

Market News
07 Oct 2026
Tokenpost
View Source
Bearish
Cybersecurity consultant convicted for $55M DeFi theft from Uranium Finance in 2021.

Jonathan Spalletta, a cybersecurity consultant, was convicted by a New York jury for stealing about $55 million from the decentralized finance protocol Uranium Finance in 2021. He exploited the protocol twice, draining 26 liquidity pools, which led to Uranium Finance shutting down. Authorities seized $31 million in cryptocurrency and valuable collectibles from Spalletta, who faces up to 20 years in prison with sentencing set for February 2027.

The conviction of Jonathan Spalletta for a $55 million theft from Uranium Finance provides context for cryptocurrency market activity. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 07, 2026 22:32 WIB: out of 50 major cryptocurrencies priced on Pluang, 5 rose and 44 fell today. Notable movers include AXS at Rp20.869 with a 1-day change of -9.24%, XTZ at Rp5.475 down 8.54%, and THETA at Rp3.854 down 8.50%.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App